Total syntheses of ipomoeassin B and E

Journal of the American Chemical Society

Volumn 129, Issue 7, 2007, Pages 1906-1907

  Fürstner, Alois ^a   Nagano, Takashi ^a  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IPOMOEASSIN A; IPOMOEASSIN B; IPOMOEASSIN C; IPOMOEASSIN D; IPOMOEASSIN E; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; EXTRACTION; HUMAN; HUMAN CELL; IPOMOEA; OVARY CANCER; OXYGENATION; RING CLOSING METATHESIS; SYNTHESIS;

GLYCOCONJUGATES; GLYCOSIDES; IPOMOEA; MOLECULAR CONFORMATION; RESINS, PLANT;

EID: 33847263491     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja068901g     Document Type: Article

References (27)

1. Cao, S.; Guza, R. C.; Wisse, J. H.; Miller, J. S.; Evans, R.; Kingston, D. G. I. J. Nat. Prod. 2005, 68, 487.
2. Plants of the morning glory family (Convolvulaceae) have been extensively used in traditional medicine as herbal remedies for various diseases: (a) Pereda-Miranda, R.; Bah, M. Curr. Top. Med. Chem. 2003, 3, 111.
3. (b) Fürstner, A. Eur. J. Org. Chem. 2004, 943.
4. For speculations about the possible mode of action of resin glycosides, see: Rencurosi, A.; Mitchell, E. P.; Cioci, G.; Pérez, S.; Peredo-Miranda, R.; Imberty, A. Angew. Chem., Int. Ed. 2004, 43, 5918.
5. For previous biochemical evaluations of glycolipids, see: (a) Fürstner, A.; Ruiz-Caro, J.; Prinz, H.; Waldmann, H. J. Org. Chem. 2004, 69, 459.
6. (b) Fürstner, A.; Albert, M.; Mlynarski, J.; Matheu, M.; DeClercq, E. J. Am. Chem. Soc. 2003, 125, 13132.
7. (a) Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18.
8. (b) Fürstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012.
9. (c) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem., Int. Ed. 2005, 44, 4490.
10. (a) Fürstner, A.; Müller, T. J. Am. Chem. Soc. 1999, 121, 7814.
11. (b) Fürstner, A.; Müller, T. J. Org. Chem. 1998, 63, 424.
12. (c) Fürstner, A.; Radkowski, K.; Grabowski, J.; Wirtz, C.; Mynott, R. J. Org. Chem. 2000, 65, 8758.
13. (d) Fürstner, A.; Jeanjean, F.; Razon, P. Angew. Chem., Int. Ed. 2002, 41, 2097.
14. (e) Fürstner, A.; Jeanjean, F.; Razon, P.; Wirtz, C.; Mynott, R. Chem.-Eur. J. 2003, 9, 307.
15. (f) Fürstner, A.; Jeanjean, F.; Razon, P.; Wirtz, C.; Mynott, R. Chem.-Eur. J. 2003, 9, 320.
16. (g) Lehmann, C. W.; Fürstner, A.; Müller, T. Z. Kristallogr. 2000, 215, 114.
17. For details, consult the Supporting Information.
18. Johansson, R.; Samuelsson, B. J. Chem. Soc., Perkin Trans. 1 1984, 2371.
19. (a) Inanaga, J.; Hirata, K.; Saeki, H.; Katsuki, T.; Yamaguchi, M. Bull. Chem. Soc. Jpn. 1979, 52, 1989.
20. (b) For a recent application in the glycolipid series, see: Mlynarski, J.; Ruiz-Caro, J.; Fürstner, A. Chem.-Eur. J. 2004, 10, 2214.
21. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953.
22. For the use of TASF in challenging O-Si-cleavage reactions, see: (a) Scheidt, K. A.; Chen, H.; Follows, B. C.; Chemler, S. R.; Coffey, D. S.; Roush, W. R. J. Org. Chem. 1998, 63, 6436.
23. (b) Aïssa, C.; Riveiros, R.; Ragot, J.; Fürstner, A. J. Am. Chem. Soc. 2003, 125, 15512.
24. More common fluoride sources or acidic conditions are inappropriate for this purpose, cf. Supporting Information.
25. (a) Kusakabe, M.; Kitano, Y.; Kobayashi, Y.; Sato, F. J. Org. Chem. 1989, 54, 2085.
26. (b) Kametani, T.; Tsubuki, M.; Tatsuzaki, Y.; Honda, T. J. Chem. Soc., Perkin Trans. 1 1990, 639.
27. Ho, T.-L.; Sapp, S. G. Synth. Commun. 1983, 13, 207.